Influx Healthtech Surges 33% on NSE SME Debut, Lists at ₹132.50 Amid Robust Demand
By Ankur Chandra | Updated at: Jan 19, 2026 09:56 AM IST
Mumbai, 25 June 2025: Influx Healthtech Limited made an impressive entry onto the NSE SME platform today, listing at ₹132.50, significantly above its issue price of ₹96. As of 14:15 IST, the stock was trading at ₹128.00, marking a 33.33% gain over the IPO price, underscoring healthy investor appetite and strong market confidence despite some midday fluctuations.
Listing Day Performance (As of 14:15 IST)
The stock opened at ₹132.50 and reached an intraday peak of ₹135.85 before dipping slightly to a low of ₹125.90. The volume-weighted average price (VWAP) stood at ₹130.90, with the share maintaining bullish momentum through the early afternoon session. At its last traded price of ₹128.00, Influx Healthtech maintained firm ground in the green, with substantial trading activity and high investor participation.
| Metric | Value |
|---|---|
| IPO Price | ₹96 |
| Listing Price | ₹132.50 |
| Last Traded Price | ₹128.00 |
| Intraday High / Low | ₹135.85 / ₹125.90 |
| VWAP | ₹130.90 |
| Market Capitalization | ₹296.33 crore |
| Traded Volume | 30.58 lakh shares |
| Traded Value | ₹40.02 crore |
| Deliverable Quantity % | 99.61% |
Order Book Snapshot (14:15 IST)
| Bid Price (₹) | Quantity | Ask Price (₹) | Quantity |
|---|---|---|---|
| 128.00 | 2,400 | 128.50 | 2,400 |
| 127.55 | 1,200 | 129.50 | 3,600 |
| 127.50 | 3,600 | 129.25 | 1,200 |
| 127.15 | 1,200 | 129.40 | 1,200 |
| 127.10 | 1,200 | 129.50 | 1,200 |
| Total Buy Qty | 75,600 | Total Sell Qty | 2,16,000 |
Price Band Information
| Detail | Value |
|---|---|
| Upper Band | ₹139.10 |
| Lower Band | ₹125.90 |
| Price Band (%) | 5% |
| Tick Size | ₹0.05 |
Strong Start Reflects Market Optimism
The stock’s robust debut reflects investor confidence in Influx Healthtech’s growth prospects and underlying fundamentals. The nearly full delivery percentage (99.61%) signals strong investor intent and limited speculative interest. While the total sell quantity outweighed buy bids as of the latest update, demand remained buoyant within the permissible trading band.
Market Outlook and Commentary
Influx Healthtech’s successful listing aligns with the broader trend of strong SME IPO interest seen in 2025. Analysts suggest that the company’s market cap of ₹296.33 crore, coupled with volume-led strength on the debut day, could pave the way for sustained momentum if earnings and business expansion plans continue to meet expectations.
Market watchers will be closely monitoring subsequent trading sessions for cues on price stabilisation and potential investor entry levels. Given the significant listing premium and delivery-backed buying, Influx Healthtech’s performance will likely remain under close investor scrutiny.
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
